These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27093468)

  • 1. Interferon-gamma is associated with hepatic dysfunction in fibrosis, cirrhosis, and hepatocellular carcinoma.
    Attallah AM; El-Far M; Zahran F; Shiha GE; Farid K; Omran MM; Abdelrazek MA; Attallah AA; El-Beh AA; El-Hosiny RM; El-Waseef AM
    J Immunoassay Immunochem; 2016; 37(6):597-610. PubMed ID: 27093468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of Schistosoma mansoni Circulating Antigen in Chronic Hepatitis C Patients with Different Stages of Liver Fibrosis.
    Attallah AM; El-Far M; Omran MM; Farid K; Attallah AA; Abd-Elaziz D; El-Bendary MS; El-Dosoky I; Ismail H
    J Immunoassay Immunochem; 2016; 37(3):316-30. PubMed ID: 26745203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
    Moussa YI; Plevris JN; Hayes PC
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):159-63. PubMed ID: 10741929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
    El-Mesery M; El-Mowafy M; Elgaml A; Youssef LF; Abed SY
    J Interferon Cytokine Res; 2017 Aug; 37(8):342-347. PubMed ID: 28609212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vascular adhesion protein-1(VAP-1): a possible biomarker for liver fibrosis associated with chronic hepatitis B and C.
    Öksüz Z; Üçbilek E; Serin MS; Yaraş S; Temel GO; Sezgin O
    Braz J Microbiol; 2020 Dec; 51(4):1757-1763. PubMed ID: 32959205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated renin levels in patients with liver cirrhosis and hepatocellular carcinoma.
    Lotfy M; El-Kenawy Ael-M; Abdel-Aziz MM; El-Kady I; Talaat A
    Asian Pac J Cancer Prev; 2010; 11(5):1263-6. PubMed ID: 21198274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-6 and interferon-gamma levels in patients with hepatitis B-associated chronic liver disease.
    Tangkijvanich P; Vimolket T; Theamboonlers A; Kullavanijaya P; Suwangool P; Poovorawan Y
    Asian Pac J Allergy Immunol; 2000 Jun; 18(2):109-14. PubMed ID: 10928624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases.
    Caversaccio NI; Reina Caro MD; Prince R; Müller M; Lewis CS; Bogdanov VY; Dufour JF; Angelillo-Scherrer A
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1470-1475. PubMed ID: 30113368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics.
    Tang JT; Fang JY; Gu WQ; Li EL
    World J Gastroenterol; 2006 May; 12(19):3015-9. PubMed ID: 16718780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis.
    Ohnishi M; Higuchi A; Matsumura H; Arakawa Y; Nakamura H; Nirei K; Yamamoto T; Yamagami H; Ogawa M; Gotoda T; Matsuoka S; Nakajima N; Sugitani M; Moriyama M; Murayama H
    Int J Med Sci; 2017; 14(7):629-638. PubMed ID: 28824294
    [No Abstract]   [Full Text] [Related]  

  • 14. IL-18 and interferon-gamma in HCV-related hepatocellular carcinoma: a model of interplay between immune status and cancer.
    Perrella O; Cuomo O; Sbreglia C; Monaco A; Gnarini MR; Gentile B; Perrella M; Perrella A
    J Biol Regul Homeost Agents; 2009; 23(4):251-8. PubMed ID: 20003764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
    Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
    Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of correlation between interferon-γ and soluble intercellular adhesion molecule-1 and interleukin-17 in hepatitis B virus-related cirrhosis.
    Chen H; Zhang D; Wang S; Wang X; Yang C
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):608-13. PubMed ID: 23796976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of efficacy of interferon treatment of chronic hepatitis C and occurrence of HCC after interferon treatment by a new classification.
    Kim KI; Sasase N; Taniguchi M; Mita K; Kim SR; Tanaka K; Hayashi Y
    Intervirology; 2005; 48(1):52-8. PubMed ID: 15785090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.
    Zekri AN; El Deeb S; Bahnassy AA; Badr AM; Abdellateif MS; Esmat G; Salama H; Mohanad M; El-Dien AE; Rabah S; Abd Elkader A
    World J Gastroenterol; 2018 Mar; 24(11):1228-1238. PubMed ID: 29568203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.
    Yagmur E; Rizk M; Stanzel S; Hellerbrand C; Lammert F; Trautwein C; Wasmuth HE; Gressner AM
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):755-61. PubMed ID: 17700260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.